Trends of cost and mortality of patients on haemodialysis with end stage renal disease.


AIM The prevalence of end-stage renal disease in Taiwan is among the highest in the world. Treatment reimbursement for haemodialysis was capped in 1996 in order to contain costs. This study evaluated temporal changes in the costs and utilization of medical care and mortality in patients receiving haemodialysis following capped reimbursement. METHODS Using… (More)
DOI: 10.1111/nep.12380